Suven Pharma to acquire Casper Pharma for $20m.

Synopsis

Suven Pharmaceuticals, a pharmaceutical company, agreed to acquire Casper Pharma, a pharmaceutical company, for $20m.

Principals

target

Casper Pharma

bidder

Suven Pharma

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (4)

aman anand

Associate at Khaitan & Co

Lawyer

target

Deals

£ 5.80 B

Total Value

nikhilesh panchal

Partner at Khaitan & Co

Lawyer

target

Deals

£ 322 M

Total Value

vimal kavuru

CEO at CASPER PHARMA

Manager

target

Deal

£ 17 M

Total Value

harshita jajodia

Associate at Khaitan & Co

Lawyer

target

Deals

£ 73 M

Total Value

Bidder Team (1)

venkat jasti

Chairman and CEO at SUVEN PHARMA

Manager

bidder

Deal

£ 17 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy